This page shows you your search results in order of relevance. This is page number 15.

Order by Relevance | Date

Total 5148657 results found since Jan 2013.

Sexual Dysfunction Levels in Iranian Women Suffering from Multiple Sclerosis
Conclusion According to this study, sexual dysfunction, especially primary SD was one of the most prevalent problems among women with MS. In addition, this study showed a complex and multifactorial nature for SD among these women. In order to provide an appropriate treatment and management of SD, associated factors and their impacts should be considered.
Source: Multiple Sclerosis and Related Disorders - January 5, 2017 Category: Neurology Source Type: research

On Dark Days With Multiple Sclerosis, Sometimes a Rainbow Breaks Through
This week began the Celtic Spring season. Before you look out at the snow banks or tell me that Punxsutawney Phil saw his shadow, so you’ve six more weeks of winter, this is an old tradition here in Ireland. For us, spring starts on the first of February with the Biddy’s Day celebrations, which have been modernized into the festival of St Brigid’s Day. But whether you call it spring or winter, it’s still the season of cold wind and driving rain. But now and again, the sun’s long, low rays break through the clouds, even if it’s still raining. Ever since my first winter here, back in 2005, I’ve referred ...
Source: Life with MS - February 6, 2017 Category: Neurology Authors: Trevis Gleason Tags: multiple sclerosis awareness comments community life with MS ms community trevis gleason Source Type: blogs

Baseline Characteristics of Pediatric Patients with Multiple Sclerosis Enrolled in the PARADIGMS Study: A Randomized, Double-Blind Study of Fingolimod versus Interferon-{beta}-1a (P1.347)
Conclusions:Patients enrolled in the PARADIGMS study had a high frequency of relapses and Gd+ lesions early in their course of the disease and the majority were at post-pubertal stage. These characteristics are in line with the previously known pediatric MS cohorts. The recruitment target has been successfully met; however recruitment remains open to enroll additional eligible pre-pubertal patients.Study Supported by: Novartis Pharma AG.Disclosure: Dr. Chitnis received personal compensation for activities with Roche-Genentech and Sanofi-Genzyme. Dr. Chitnis received research support from EMD Serono, Biogen, Novartis and Ve...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Chitnis, T., Arnold, D., Banwell, B., Bruck, W., Ghezzi, A., Giovannoni, G., Greenberg, B., Krupp, L., Rostasy, K., Tardieu, M., Waubant, E., Wolinsky, J., Bar-Or, A., Stites, T., Jessop, N., Merschhemke, M. B., Gartner, J. Tags: Pediatric Multiple Sclerosis Source Type: research

Identification of the flotillin-1/2 heterocomplex as a target of autoantibodies in multiple sclerosis (P1.393)
Conclusions:Autoantibodies against the flotillin-1/2 heterocomplex, a peripheral membrane protein that is involved in axon outgrowth and regeneration of the optic nerve, seem to be specific for a small subset of patients with multiple sclerosis.Disclosure: Dr. Hahn has nothing to disclose. Dr. Trendelenburg has nothing to disclose. Dr. Scharf has nothing to disclose. Dr. Denno has nothing to disclose. Dr. Brakopp has nothing to disclose. Dr. Teegen has nothing to disclose. Dr. Probst has nothing to disclose. Dr. Wandinger has nothing to disclose. Dr. Buttmann has received personal compensation from Almirall Hermal GmbH for...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Hahn, S., Trendelenburg, G., Scharf, M., Denno, Y., Brakopp, S., Teegen, B., Probst, C., Wandinger, K.-P., Buttmann, M., Szabados, F., vom Dahl, M., Kumpfel, T., Eichhorn, P., Gold, H.-J., Paul, F., Jarius, S., Melzer, N., Stocker, W., Komorowski, L. Tags: Biomarkers and Experimental Studies for Multiple Sclerosis I Source Type: research

Localized over expression of FGF9 in the rat motor cortex reproduces the pathological features of grey matter lesions in progressive multiple sclerosis. (P2.364)
Conclusions:Increasing availability of FGF9 in the rat cortex results in demyelinated lesions that recapitulate the major pathological features associated with grey matter lesions in progressive multiple sclerosis. This observation combined with data demonstrating FGF9 expression is increased in patients identifies FGF9-dependent responses as a logical target for therapies designed to reduce accumulation of disability in patients with progressive disease.Study Supported by: Funding for this study was provided by the Hertie Foundation, Multiple Sclerosis Society and the Naomi Bramson Trust.Disclosure: Dr. Wrzos has nothing ...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Wrzos, C., McElroy, D., Thuemmler, K., Sebastian, S., Junker, A., Stadelmann-Nessler, C., Linington, C. Tags: Biomarkers and Experimental Studies for Multiple Sclerosis II Source Type: research

Intra Individual Variability in Reaction Time Is Sensitive Across the Lifespan in Multiple Sclerosis (P4.352)
Conclusions:IIV in reaction time tasks may be used as a sensitive measure of performance variability in patients with MS and is related to cognitive performance as well. IIV is impaired in MS across the lifespan, including pediatric patients. IIV is a novel and sensitive marker of cognitive involvement in patients with MS, and may predict future cognitive decline as in other diseases.Study Supported by: The Lourie Center for Pediatric Multiple Sclerosis, the Department of Defense, and the National Multiple Sclerosis Society.Disclosure: Dr. Pau has nothing to disclose. Dr. Shaw has nothing to disclose. Dr. Patel has nothing...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Pau, W., Shaw, M., Patel, R., Kasschau, M., Song, G., Krupp, L., Charvet, L. Tags: Cognitive Impairment in Multiple Sclerosis: Clinical and MRI Correlates Source Type: research

Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients with Primary Progressive Multiple Sclerosis in the ORATORIO Trial (P4.384)
Conclusions:In the ORATORIO trial, ocrelizumab increased by approximately 3-fold the proportion of patients with NEPAD vs placebo, as measured by the combination of no evidence of progression, no relapse and no MRI activity. NEPAD may represent a useful composite outcome to assess the absence of clinical and MRI features of disease progression and activity in patients with PPMS.Study Supported by:Sponsored by F. Hoffmann-La Roche Ltd.Disclosure: Dr. Wolinsky has received personal compensation for activities with AbbVie, AcademicCME, Alkermes, Bayer HealthCare, Forward Pharma A/S, Novartis, Roche/Genentech, Sanofi Genzyme, ...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Wolinsky, J., Montalban, X., Kappos, L., Hauser, S., Giovannoni, G., de Seze, J., Bar-Or, A., Masterman, D., Bernasconi, C., Wei, W., Garren, H., Chin, P., Belachew, S., Arnold, D. Tags: No Evidence of Disease Activity in Multiple Sclerosis Source Type: research

Efficacy of Ocrelizumab on Brain MRI Outcomes in Patients with Early Relapsing Multiple Sclerosis: Pooled Analysis of the OPERA Studies (P6.338)
Conclusions:Ocrelizumab reduced brain MRI lesion activity and the rate of brain volume loss vs IFNβ-1a in patients with early RMS.Study Supported by:Sponsored by F. Hoffmann-La Roche Ltd.Disclosure: Dr. Traboulsee has received personal compensation for activities with Genzyme and Roche as a consultant. Dr. Traboulsee has received research support from Genzyme, Roche, and Chugai. Dr. Hauser has received personal compensation for activities with Annexon, Symbiotix, Bionure as a scientific advisory board member and from F. Hoffmann-La Roche Ltd. Dr. Havrdova has received personal compensation for activities with Biogen, ...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Traboulsee, A., Hauser, S., Havrdova, E., Kappos, L., Racke, M., Selmaj, K., Belachew, S., Bernasconi, C., Buffels, R., Garren, H., Wei, W., Arnold, D. Tags: Disease Modifying Therapy for Multiple Sclerosis: Efficacy and Clinical Trial Outcomes I Source Type: research

The effect of alcohol and red wine consumption on clinical and MRI outcomes in multiple sclerosis
Conclusions Higher total alcohol and red wine intake were associated with a lower cross-sectional level of neurologic disability in MS patients but increased T2LV accumulation. Further studies should explore a potential cause-effect neuroprotective relationship, as well as the underlying biological mechanisms.
Source: Multiple Sclerosis and Related Disorders - July 7, 2017 Category: Neurology Source Type: research

Infectious mononucleosis and multiple sclerosis – Updated review on associated risk
Discussion Overall, new literature on IM and risk of MS categorically supports the association. Future work should focus on other risk factors such as age and gender on IM and subsequent risk of MS.
Source: Multiple Sclerosis and Related Disorders - July 7, 2017 Category: Neurology Source Type: research

Hopeful Cord Blood Treatment for Multiple Sclerosis
Multiple Sclerosis (MS) is a disabling disease of the central nervous system that disrupts the flow of information within the brain, and between the brain and body. Our central nervous system is covered in myelin, a “fatty white substance” that surrounds and protects the nerve fibers that are responsible for transmitting information to the brain, spinal cord, and the rest of the body. Multiple sclerosis attacks and destroys the myelin and as these nerve cells deteriorate, symptoms of MS such as “numbness, loss of vision, fatigue and tremors” start to occur. There are different phases or “courses” of MS most oft...
Source: Cord Blood News - July 24, 2017 Category: Perinatology & Neonatology Authors: Maze Cord Blood Tags: Cord Blood medical research stem cells multiple sclerosis Source Type: blogs

Diagnostic evaluation of dysphagia in multiple sclerosis patients using a Persian version of DYMUS questionnaire
Conclusion The oropharyngeal dysphagia in MS patients is very common even in early stages of the disease; therefore, it is important to assess these patients carefully and to initiate a treatment program if needed.
Source: Multiple Sclerosis and Related Disorders - September 2, 2017 Category: Neurology Source Type: research

Next: Brain scans to identify children at high risk of developing multiple sclerosis (MS) before symptoms appear
Conclusions: We describe the clinical characteristics and outcomes of children with incidental MRI findings highly suggestive of CNS demyelination. Children with RIS had a substantial risk of subsequent clinical symptoms and/or radiologic evolution. The presence of oligoclonal bands in CSF and spinal cord lesions on MRI were associated with an increased risk of a first clinical event. News in Context Next: Harnessing brain scans to personalize autism-related behavioral interventions Can brain scans identify ADHD and help predict treatment response? Brain waves help predict stress-related sleep problems Cognitive therapy ...
Source: SharpBrains - October 18, 2017 Category: Neuroscience Authors: SharpBrains Tags: Cognitive Neuroscience Health & Wellness Technology brain changes brain-scans clinical headache MRI MS multiple-sclerosis radiologic radiologically isolated syndrome RIS Source Type: blogs

Epidemiological and clinical characteristics of multiple sclerosis in paediatric population in Slovenia: A descriptive nation-wide study
Conclusion The clinical pattern of pMS in our cohort of patients was characterized by polysymptomatic presentation and predominantly sensory symptoms at onset, developing a relapsing-remitting pMS pattern. It is important to gather more information about the incidence of pMS and its initial presentation and clinical course to improve early recognition and appropriate initiation of immunomodulatory treatment.
Source: Multiple Sclerosis and Related Disorders - November 12, 2017 Category: Neurology Source Type: research